Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist.

Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist.

Item
http://www.wikidata.org/entity/Q35762215
β-arrestin1 at the cross-road of endothelin-1 signaling in cancerThe role of endothelin-1 and endothelin receptor antagonists in inflammatory response and sepsisEndothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptorThe challenge of targeting metastasis.Endothelin receptor-A is required for the recruitment of antitumor T cells and modulates chemotherapy induction of cancer stem cellsmiR-30a inhibits endothelin A receptor and chemoresistance in ovarian carcinoma.Endothelin therapeutics in cancer: Where are we?Nuclear β-arrestin1 is a critical cofactor of hypoxia-inducible factor-1α signaling in endothelin-1-induced ovarian tumor progression.Evaluation of the endothelin receptor antagonists ambrisentan, bosentan, macitentan, and sitaxsentan as hepatobiliary transporter inhibitors and substrates in sandwich-cultured human hepatocytes.Macitentan: first global approval.Macitentan: An important addition to the treatment of pulmonary arterial hypertension.Blocking endothelin-1-receptor/β-catenin circuit sensitizes to chemotherapy in colorectal cancerMacitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia.Targeting endothelin-1 receptor/β-arrestin1 network for the treatment of ovarian cancer.hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.Upregulation of Endothelin-1/Endothelin A Receptor Expression Correlates with Heparanase Expression in Ovarian Carcinoma.
P2860

Antivascular therapy for multidrug-resistant ovarian tumors by macitentan, a dual endothelin receptor antagonist.

Item
http://www.wikidata.org/entity/Q35762215
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Antivascular therapy for multi ...... ndothelin receptor antagonist.
@ast
Antivascular therapy for multi ...... ndothelin receptor antagonist.
@en
type
label
Antivascular therapy for multi ...... ndothelin receptor antagonist.
@ast
Antivascular therapy for multi ...... ndothelin receptor antagonist.
@en
prefLabel
Antivascular therapy for multi ...... ndothelin receptor antagonist.
@ast
Antivascular therapy for multi ...... ndothelin receptor antagonist.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Antivascular therapy for multi ...... ndothelin receptor antagonist.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932